Loading...
A new analysis from the U.S. National Health and Nutrition Examination Survey (NHANES) from 2015 to 2020 suggests disparities in use of statins by race, ethnicity, and sex might be widespread. Among 4800 people who were eligible for primary prevention statin therapy (according to 2013 and 2018 American College of Cardiology/American Heart Association cholesterol guidelines) and among 1100 people who were eligible for secondary prevention statin therapy (due to diagnosed cardiovascular disease), adjusted analyses revealed the following:
For primary prevention, non-Mexican Hispanic women and non-Hispanic Black men were less likely to use statins than were non-Hispanic white men (adjusted prevalence ratios, 0.7).
For secondary prevention, use of…